1. Home
  2. WYNN vs RGEN Comparison

WYNN vs RGEN Comparison

Compare WYNN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wynn Resorts Limited

WYNN

Wynn Resorts Limited

HOLD

Current Price

$87.09

Market Cap

10.1B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$165.00

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WYNN
RGEN
Founded
2002
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
9.5B
IPO Year
2002
1995

Fundamental Metrics

Financial Performance
Metric
WYNN
RGEN
Price
$87.09
$165.00
Analyst Decision
Strong Buy
Buy
Analyst Count
15
12
Target Price
$142.73
$167.67
AVG Volume (30 Days)
1.5M
920.0K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
0.96%
N/A
EPS Growth
N/A
286.96
EPS
2.36
0.24
Revenue
$6,717,660,000.00
$141,236,000.00
Revenue This Year
$6.49
$14.30
Revenue Next Year
$4.58
$14.52
P/E Ratio
$38.23
$687.71
Revenue Growth
10.67
35.10
52 Week Low
$89.44
$100.99
52 Week High
$134.72
$188.73

Technical Indicators

Market Signals
Indicator
WYNN
RGEN
Relative Strength Index (RSI) 29.94 45.83
Support Level N/A $156.65
Resistance Level $107.47 $167.74
Average True Range (ATR) 2.30 6.66
MACD -0.71 -2.82
Stochastic Oscillator 5.23 8.96

Price Performance

Historical Comparison
WYNN
RGEN

About WYNN Wynn Resorts Limited

Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming rooms and attractions in Macao over the next few years, including a new 432-suite tower adjacent to its Palace resort opening in 2029. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company received 49% and 51% of its 2025 prepandemic EBITDA from Macao and the US, respectively.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: